We now have evidence that some of those who invested in Bluebird (BMV) at the IPO are ignoring lock-ins. That is seeing the shares slip when they should be racing on more good news. We expect this matter to be resolved very shortly indeed and the re-rate to then start and to be dramatic. That makes the shares a buy now.
Both Tom and I have been critical of Boxhill Technologies in this year and the full series of articles can be seen HERE, so I felt it was appropriate to applaud a few baby steps in the right direction set out in Friday’s announcement “Corporate Update and Board Changes”.
A curious filing has appeared at Companies House with regard to our dear friends at Daniel Stewart (DAN), the formerly AIM-listed company which used to be a Nomad, used to have a Nomad and which is still a Broker. Back in January a debenture in favour of the mysterious Asian outfit Epsilon appeared at Companies House: it seems that the parent company had entered into an arrangement with its largest shareholder in return for a charge over all its assets, as was covered at the time by Tom Winnifrith. Now we appear to have one covering all the assets of the only operating subsidiary.
Last week I promised you a love letter to new London mayor Sadiq Khan. Actually, I don't have much to say about him other than if he drives Tom so mad, he must have some redeeming qualities. TW Note, I said I was glad Khan won, check your facts beardie,
We polled you on Friday asking which oil mid cap did you think would follow Circle Oil (COP) in admitting that there would be little or no value left for shareholders. Which is the next oil company to admit that it is toast. And your verdict was clear. I would say that it is probably a tight race between the gold and silver medalists in this poll. You voted:
OptiBiotix Health (OPTI) has announced that it has filed a new patent to protect advances made in its skin division in identifying microbial proteins which have the potential to prevent Health Care Acquired Infections (HCAI) caused by antimicrobial resistant (AMR) superbugs such as MRSA. The company says HCAIs lead to higher morbidity and mortality, and cost the NHS an estimated £1 billion per year. This represents a global market opportunity of $82 billion.
George Osborne says UK house prices will fall by 18% if we vote for Brexit. At every single conceivable level he is talking bollocks. Even the lovely Cheryl Cole can testify to that as I explain in today's podcast.
Rick Rule of Sprott is still a long term gold bull but he has warned that after a good run some of the gold equities could see some consolidation or pull back unless gold itself moves ahead again. On the upside he notes in this week's podcast with Amanda van Dyke's colleagues at Palisade Capital he discuses what happens if there is a major exploration success somewhere
Platinum prices have recovered very well since the early part of the year and have been consistently trading at above the $1,000 area, a big increase on the lows of around $810 that we saw.
Following my 16th May review of the AGM trading update of provider of trading and risk management software to the commodity and energy markets, Brady plc (BRY), the company’s CEO Gavin Lavelle has been in touch to talk about the background of its 2015 and recently reported performance…
Fox Marble (FOX) has announced that its “order book has increased to €3.9 million for the year” and developments offering further potential.
A couple of months on since our last update and more ShareProphets China AIM 'Filthy Forty' companies have followed Geong International and co in 'Geong, Geong' and then gone...
Hello Share Chunterers. Gold is flavour of the month, if not the next few years. So let’s take another peek at Centamin (CEY) the Egyptian gold producer. Now this poor country has got it in the neck again this week with an aeroplane destined for that country tragically falling out of the sky*.
This morning it was announced that SDX Energy Inc (SDX) had joined the AIM Casino, to add to its TSX-V listing in Canada. Welcome to the mad-house. But reading through the admission and first day of dealings RNS a few things jump out at me. I wonder if it is already one to be avoided like the plague.
Shares in R4E (R4E) have raced ahead to 2,2-2.25p on news that Gate Ventures, the vehicle of controversial entrepreneur Johnny Hon has taken its holding up to 17%. No make that 18%, the TR1's come thick and fast.
In a very British way I start by complaining about the weather. Right now it is sheeting it down here in Greece. Then onto Plethora/Regent Pacific before tackling what the phrase "little or no value" actually means ref Circle Oil (COP). Then onto African Potash (AFPO) and I answer the questions it will not. Target price 0p.
Tom Winnifrith recently suggested that Port Erin Biopharma (PEBI) has gone limp because of pessimism about Plethora's premature ejaculation treatment. Cynical Bear says be suspicious of sub-scale investment companies on AIM, full of related party transactions and corporate overheads. So… obviously the moronic thing to do is pile in, right? But still, I am long Port Erin, at least when the price is right (sub 4p). Here’s why.
Dublin-based petrol filling station group Applegreen (APGN) held its AGM this morning and updated the market with respect to trading so far this year. This high-growth business looks like it has the potential to become a genuine AIM success story, having listed less than a year ago. Many IPOs have turned sour recently, but Applegreen isn’t one of them.
I pointed out yesterday that Environmental Recycling (ENRT), the company formerly known as 3DM and which is the only AIM company to have been censured not once but twice by the FSA (now the FCA) for lying to investors was drowning in debt and out of cash. Just to show how out of cash it is, I point out that it cannot even afford to pay a vital bill for Euro 1,575.
A Thursday 2:21pm “Trading Update”. Hmmm. “Mobile Streams plc (MOS) updates the market on its expectations for the current financial year ending 30 June 2016”. Uh oh…
The April edition of the UK Investor Show Magazine is live featuring Metal Tiger, BMR, Harley Investments, Action Hotels and much more.
This week's contest is graciously sponsored by African Potash, AIM, NEX, Chris Cleverly vehicle that is bound to hit the stratosphere.*
The A-Grade A'holes at Walbrook PR who charge Optibiotix (OPTI) thousands of quid a month for "news management" probably thought putting out two announcements on one day was part of a clever strategy. Whatever. If Optibiotix wants to save a few quid we have a suggestion....
Given that the company is now producing gold, I’ve been somewhat surprised by the lacklustre response that the market has given Ariana Resources (AAU) since that news came.
Fraud Cloudtag (CTAG) may have been booted off the AIM Casino but in the few months before insolvency the comedy continues. The company has held an AGM the highlight of which was news that the 2 NEDS Tony Reeves and Jerry Bereika have resigned. Lyin' Amit Ben Haim says that the a search for new directors with the requisite skills to match the Company’s future requirements is underway. Hmmm what would that skillset be?
In this video from the storming success that was the 2017 UK Investor Show, Tom Winnifrith interviews Mark Slater. And make sure that you keep April 21 2018 free for next year's UK Investor Show.
Concepta (CPT) wants to know why its shares are nor racing away although having tipped this at an 11p offer we are, at 16.5p, well up.? Simple. It announced last autumn that it was about to sell its MyLotus kits in China and since then it has appointed a country manager and huffed and puffed but there are no sign of those sales. And against that background after calendar 2016 results the shares are just 16.5p mid. But before you sell hang on a second...the shares are actually a stonking buy if yoiu can get them at 16p or underand here is why.
Naughty naughty naughty. On Tuesday night Ve Interactive, the daft money guzzling new media start up into which Concha (CHA) unwisely invested on a £1 billion valuation went into administration and was at once bought ( one assumes for peanuts) by management and certain existing shareholders. Since Concha has not a lot of cash it is hard to see it being involved. But where is the statement? AIM Rules say something about timely disclosure yet we have had 24 hours with no RNS. Nope make that 36 hours...
Caption this very accurate and not at all cropped photo of some nice Tories in the comments below. The deadline is midnight tonight.
Hello Share Monkeys. Quite a few of my more moribund penny shares are in revival mode at the mo. Which is unusual. Because when the Footsie rises, investors are more likely to get income from more reliable outlets. Why risk the huge volatility of the cheaps when you can make money investing in companies with big cash piles and ever growing profits, i.e: most of the Footsie members?
Floated at 33p by Lagos Securities, or Cenkos as it prefers to be known, on the back of a prospectus that forgot to mention critical damaging information, Rosslyn Data (RDT) has been a serial disappointer and was clearly set to run out of cash this year, despite numerous protestations from its discredited management that this was not the case. And so today, the oldest trick in the book - a bailout placing dressed up as an acquisition. The price of the bailout, just 4.5p.
The world's best known resource investors Sprott says that its investment thesis for gold is significantly long-term in scope.It explains clearly why recent gains will continue and that means you all need an exposure to the yellow metal. Over to Sprott:
Kefi Minerals (KEFI) has announced another box has been ticked as it moves towards constructing the Tulu Kapi gold mine in Ethiopia. It has finally agreed with the Government plans to resettle the folks who live around the mine away from operations. And with that done it states "The objective for the Government of Ethiopia and KEFI is for construction to commence in H2-17."
Collagen Solutions (COS) has announced growth “driven by an increase in the number of customers, higher volumes from key customers and an increase in new development agreements”, sparking the shares higher…
Amryt Pharma (AMYT) has announced that the first patient has now been enrolled in its phase three trial of AP101, a potential treatment for the rare, genetic skin disorder, Epidermolysis Bullosa - a market worth £1 billion.
London main-market listed, gold miner in Russia Petropavlovsk (POG) has announced results for the 2016 calendar year, emphasising a return to profitability and a refinancing of bank debt - enabling it not to have to divest part of the value in its core organic growth development project, the POX Hub…
We have long pointed out what a dog Green Dragon (GDG) is. Its failure to answer the questions in the bloody dossier HERE was the biggest red flag. Now the City's top oil analyst, Zac "the Knife" Phillips of SP Angel has gone on the attack, calling for regime change and warning that the company's assets could end up with its creditors, i.e. the equity could be worthless. The Knife writes:
Together Robert Sutherland Smith and Tom Winnifrith have now been working in finance for 71 years - the last ten or so together. Tom wishes to stress that RSS accounts for most of that, the great value investor starting his City career at the Unilever Pension Fund the year before Tom was born. In this book they outline 71 tricks of the trade for making money from shares.
Get the first ShareProphets Pocket Guide ebook, EIS - Buying shares with numerous tax breaks. Want to cut your income tax bill, get loss relief if your AIM listed shares go down, pay no CGT, avoid IHT - EIS could be the way and this book explains how.
Most investment books seem to be large enough to keep the front door open and while some contain gems it is hard to find them amid the verbiage. The aim here is to produce a short guide which simply cuts to the chase. I hope that it will provide food for thought for everyone from beginner to expert but whoever you are it should be quick and easy to read and digest.
Search ShareProphets |
Stock market news |
Recent Comments |